Afya (NASDAQ:AFYA – Free Report) had its price objective cut by JPMorgan Chase & Co. from $25.00 to $20.50 in a research report report published on Friday,Benzinga reports. They currently have a neutral rating on the stock.
Separately, The Goldman Sachs Group started coverage on shares of Afya in a report on Tuesday, December 3rd. They set a “sell” rating and a $16.00 target price for the company. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $19.60.
Get Our Latest Analysis on Afya
Afya Trading Up 0.6 %
Institutional Investors Weigh In On Afya
Hedge funds and other institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC increased its position in Afya by 19.7% during the second quarter. Renaissance Technologies LLC now owns 266,500 shares of the company’s stock worth $4,704,000 after acquiring an additional 43,800 shares during the period. Marshall Wace LLP increased its holdings in shares of Afya by 41.8% during the second quarter. Marshall Wace LLP now owns 336,985 shares of the company’s stock worth $5,948,000 after purchasing an additional 99,416 shares during the period. Cubist Systematic Strategies LLC raised its position in shares of Afya by 136.9% in the second quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company’s stock valued at $622,000 after buying an additional 20,370 shares in the last quarter. Millennium Management LLC raised its position in shares of Afya by 45.0% in the second quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock valued at $5,139,000 after buying an additional 90,383 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Afya in the third quarter valued at approximately $417,000. Institutional investors and hedge funds own 88.02% of the company’s stock.
About Afya
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Stories
- Five stocks we like better than Afya
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Stock Dividend Cuts Happen Are You Ready?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What Makes a Stock a Good Dividend Stock?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.